Titre :
  • Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.
Auteur : Verset, Gontran ; Verslype, Chris ; Reynaert, Herwig ; Borbath, Ivan ; Langlet, Philippe ; Vandebroek, A ; Peeters, Michel ; Houbiers, Ghislain ; Francque, S ; Arvanitakis, Marianna ; Van Laethem, Jean-Luc
Informations sur la publication : British Journal of Cancer, 97, 5, (page 582-588)
Statut de publication : Publié, 2007-09
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Hepatocellular carcinoma (HCC)
Octreotide
Somatostatin analogues
Tamoxifen
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Carcinoma, Hepatocellular -- drug therapy -- metabolism -- pathology
Diarrhea -- chemically induced
Female
Humans
Liver Neoplasms -- drug therapy -- metabolism -- pathology
Male
Middle Aged
Multivariate Analysis
Nausea -- chemically induced
Neoplasm Staging
Octreotide -- administration & dosage -- adverse effects
Patient Compliance -- statistics & numerical data
Prognosis
Quality of Life
Survival Analysis
Tamoxifen -- administration & dosage -- adverse effects
Treatment Outcome
alpha-Fetoproteins -- metabolism
Note : Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0007-0920 
info:doi/10.1038/sj.bjc.6603901
info:pii/6603901
info:pmid/17687341
info:pmcid/PMC2360361